VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
UNMA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
UNMAUnum Group 6.250% JR NT58
$21.48$4.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksUNMAQuarterly Financials

Unum Group 6.250% JR NT58 (UNMA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Unum Group 6.250% JR NT58 (UNMA) quarterly income statement — complete revenue, gross profit & net income history

UNMA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue3.36B3.24B3.36B3.35B3.08B3.2B3.2B3.21B3.18B3.12B3.07B3.09B3.02B2.99B2.95B2.99B2.95B2.94B2.93B2.99B
Revenue Growth %9.02%1.25%4.85%4.39%-3.24%2.52%4.34%3.6%5.23%4.46%4.14%3.59%2.4%1.83%0.53%-0.22%-2.99%-30.21%-1.85%-2.19%
Medical Costs & Claims2B1.89B2.62B2.28B2.17B2.15B95.6M2.09B2.06B2.08B2.21B2B1.99B2.03B1.74B2.04B2.15B2.23B2.02B2.12B
Medical Cost Ratio %59.73%58.38%78.01%68.05%70.41%67.1%2.99%65.25%64.71%66.54%72.09%64.55%65.79%67.77%58.93%68.41%72.81%75.79%68.98%70.84%
Gross Profit1.35B1.35B738.2M1.07B910.5M1.05B3.11B1.11B1.12B1.05B856.5M1.1B1.03B963.9M1.21B943.3M802.6M711M909.4M872.9M
Gross Margin %40.27%41.62%21.99%31.95%29.59%32.9%97.01%34.75%35.29%33.46%27.91%35.45%34.21%32.23%41.07%31.59%27.19%24.21%31.02%29.16%
Gross Profit Growth %48.4%28.09%-76.24%-4.01%-18.87%0.8%262.7%1.55%8.54%8.43%-29.24%16.25%28.83%35.57%33.1%8.07%15.35%17.64%10.24%-4.42%
Operating Expenses1.05B1.13B683.7M651.9M666.9M608.1M2.22B618.1M626.6M616.5M594.8M598.2M582.7M603M568.8M504.1M506.9M519.3M499.5M610.3M
OpEx / Revenue %31.25%34.89%20.36%19.48%21.67%18.99%69.33%19.29%19.7%19.74%19.38%19.34%19.28%20.17%19.3%16.88%17.17%17.68%17.04%20.39%
Depreciation & Amortization031.2M31.6M30.2M30M26.2M30.6M29.2M30.1M27.9M28.1M26M26.8M27M26.8M26.7M30M29.8M30.4M30.3M
Combined Ratio %90.98%93.26%98.38%87.54%92.08%86.09%72.32%84.54%84.41%86.28%91.47%83.89%85.07%87.93%78.23%85.29%89.98%93.47%86.02%91.23%
Operating Income302.7M218.4M54.5M417M243.6M445.5M886.4M495.5M495.7M428.7M261.7M498.4M451.3M360.9M641.6M439.2M295.7M191.7M409.9M262.6M
Operating Margin %9.02%6.74%1.62%12.46%7.92%13.91%27.68%15.46%15.59%13.72%8.53%16.11%14.93%12.07%21.77%14.71%10.02%6.53%13.98%8.77%
Operating Income Growth %24.26%-50.98%-93.85%-15.84%-50.86%3.92%238.71%-0.58%9.84%18.79%-59.21%13.48%52.62%88.26%56.53%67.25%48.74%53.73%36.82%-22.22%
EBITDA302.7M249.6M86.1M447.2M273.6M471.7M917M524.7M525.8M456.6M289.8M524.4M478.1M387.9M668.4M465.9M325.7M221.5M440.3M292.9M
EBITDA Margin %9.02%7.7%2.56%13.37%8.89%14.73%28.64%16.37%16.53%14.62%9.44%16.95%15.82%12.97%22.68%15.6%11.03%7.54%15.02%9.79%
Interest Expense53.1M52.6M52.2M52M52M52.5M49.2M49.9M49.5M49.2M48.6M48.9M48.1M47.2M47M47.4M46.9M50.6M44.7M45.3M
Non-Operating Income0-52.6M-52.2M-52M-52M-52.5M22.6M-49.9M-49.5M-49.2M-48.6M-48.9M-48.1M-47.2M-47M-47.4M-46.9M-50.6M-44.7M-45.3M
Pretax Income302.7M218.4M54.5M417M243.6M445.5M814.6M495.5M495.7M428.7M261.7M498.4M451.3M360.9M641.6M439.2M295.7M191.7M409.9M262.6M
Pretax Margin %9.02%6.74%1.62%12.46%7.92%13.91%25.44%15.46%15.59%13.72%8.53%16.11%14.93%12.07%21.77%14.71%10.02%6.53%13.98%8.77%
Income Tax70.7M44.3M14.8M81.4M54.5M96.8M168.9M106M100.5M98.1M59.7M105.5M93M81.3M131.3M71.9M55.3M32M81.3M79.7M
Effective Tax Rate %23.36%20.28%27.16%19.52%22.37%21.73%20.73%21.39%20.27%22.88%22.81%21.17%20.61%22.53%20.46%16.37%18.7%16.69%19.83%30.35%
Net Income232M174.1M39.7M335.6M189.1M348.7M645.7M389.5M395.2M330.6M202M392.9M358.3M279.6M510.3M367.3M240.4M159.7M328.6M182.9M
Net Margin %6.91%5.37%1.18%10.03%6.14%10.89%20.16%12.15%12.43%10.58%6.58%12.7%11.85%9.35%17.32%12.3%8.14%5.44%11.21%6.11%
Net Income Growth %22.69%-50.07%-93.85%-13.84%-52.15%5.47%219.65%-0.87%10.3%18.24%-60.42%6.97%49.04%75.08%55.3%100.82%57.12%17.95%42.19%-31.11%
EPS (Diluted)1.411.040.231.921.061.923.462.052.041.691.021.981.801.392.531.811.180.781.600.89
EPS Growth %33.02%-45.83%-93.35%-6.34%-48.04%13.61%239.22%3.54%13.33%21.58%-59.68%9.39%52.54%78.21%58.13%103.37%57.33%18.18%41.59%-31.54%
EPS (Basic)1.411.040.231.931.061.933.462.052.051.701.031.991.811.412.551.831.190.781.610.89
Diluted Shares Outstanding164.4M168.04M170.59M174.43M178.88M181.64M186.88M190.33M193.27M195.48M197.13M198.14M199.52M200.9M201.7M202.43M203.5M204.24M205.14M205.27M